Common plateau scenarios include: The circulation bottleneck: repair stalls because nutrient delivery is insufficient The remodeling bottleneck: pain improves but stability does not return The inflammation bottleneck: repair attempts are repeatedly interrupted by flare cycles The structure bottleneck: collagen forms but remains disorganized and weak GLOW is designed to support these simultaneously
At nanomolar concentrations (1 to 10 nM), it stimulates collagen, glycosaminoglycan, and proteoglycan synthesis in dermal fibroblasts
At BOC Sciences, we understand that no two drugs are identical, and many present unique formulation challenges
Immunity and collagen support
Food intake was not impacted, and any observable side effects or toxicity were negligible to the point where they should not be taken seriously
In addition, for each biological replicate, 3 technical replicates were performed